Abstract:BackgroundBeta blockers form one of the mainstay therapies for myocardial infarction (MI). Preclinical studies have shown efficacy and safety of thyroid hormone (TH) treatment of cardiovascular disorders. Although THs interact with the sympathoadrenal system at various levels, crosstalk between TH signaling and β‐adrenergic signaling remains poorly understood. We compared pathophysiologic and TH‐adrenergic signaling changes between therapeutic doses of triiodothyronine (T3) and metoprolol (Met) in rats with MI.MethodsFemale Sprague‐Dawley rats aged 12 weeks underwent left anterior descending coronary artery ligation (MI) or sham surgeries. T3 (5 μg/kg/d) or Met (100 mg/kg/d) were given in drinking water immediately after surgery for 8 weeks. At terminal experiments, rats were subjected to morphological, functional, and molecular examination.ResultsT3 and Met significantly enhanced left ventricular (LV) fractional shortening (LVFS 21.4±2.6% and 21.1±3.7%, respectively) compared to untreated MI (17.9±1.2%) and decreased the incidence of inducible atrial tachyarrhythmia by 87.5% and 62.5% without producing untoward effects. Although both treatments showed efficacy, T3 but not Met showed statistically significant improvements compared to MI in arrhythmia duration, left atrial diameter (T3 vs MI 4.3±0.6 vs. 5.7±1.3 mm, p<0.05; Met 4.9±1.1), fibrosis (6.1±0.6%, 6.6±0.6% vs. 8.2±0.7%, T3, Met vs. MI, respectively) and aortic vasorelaxation responsiveness (pD2 6.97±0.22, 6.83±0.21 vs. 6.66±0.22, T3, Met vs MI, respectively). Quantitative PCR showed that T3 and Met attenuated expression of genes associated with inflammation and oxidative stress and restored expression of ion channels and contractile proteins compared to MI rats. Importantly, thyroid and β‐adrenergic signaling genes were favorably regulated by both treatments.ConclusionThese results support comparable efficacy of long‐term treatment with a physiological dose of T3 that is comparable to Met and suggest a potential therapeutic alternative to standard β‐blockade for patients intolerant to treatment with β‐blockers after MI.Support or Funding InformationThis work was supported by the National Heart, Lung, and Blood Institute of the NIH, Bethesda, MD, under Award Number R01HL103671 (AG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledged the National Natural Science Foundation of China (No. 81470485), Capital Clinical Featured Application Research Project (NO. z151100004015175) and CAMS Innovation Fund for Medical Sciences (CIFMS 2016‐I2M‐1‐009).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Impact of thyroid hormone replacement therapy on the course and functional outcome of aneurysmal subarachnoid hemorrhage

Alteration of Thyroid-Related Hormones Within Normal Ranges and Early Functional Outcomes in Patients with Acute Ischemic Stroke

Thyroid hormones and functional outcomes after ischemic stroke

Elevated Thyroid Autoantibodies And Intracranial Stenosis In Stroke At An Early Age

TPO-Ab Plays a Role in Arterial Remodeling in Patients with Intracranial Stenosis

Correlation between thyroid autoantibodies and intracranial arterial stenosis in stroke patients with hyperthyroidism.

The Prognostic Value of Total T3 after Acute Cerebral Infarction is Age-Dependent: a Retrospective Study on 768 Patients

Thyroid hormones and stroke, the gap between clinical and experimental studies

Acute Diffuse And Transient Thyroid Swelling After Intravenous Thrombolysis For Acute Ischemic Stroke A Case Report

Prognostic value of subclinical thyroid dysfunction in ischemic stroke patients treated with intravenous thrombolysis.

Enhancement of neuroprotective and anti-edema action in mice ischemic stroke model using T3 loaded nanoparticles

Causal role of thyroid function in functional outcome after ischemic stroke: A Mendelian randomization study

Factors and Mechanisms of Thyroid Hormone Activity in the Brain: Possible Role in Recovery and Protection

Antioxidant effects of the synthetic thyronamine analogue in experimental cerebral ischemia

Efficacy of Thyrotropin-Releasing Hormone Analog for Protracted Disturbance of Consciousness due to Aneurysmal Subarachnoid Hemorrhage

Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery

Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation

The Role of Thyroid Hormone in Neuronal Protection

Thyroid Function Affects the Risk of Post-stroke Depression in Patients with Acute Lacunar Stroke.

Thyroid Hormone Supplementation Restores Cognitive Deficit, Insulin Signaling, and Neuroinflammation in the Hippocampus of a Sporadic Alzheimer's-like Disease Rat Model

Crosstalk Between Thyroid Hormone Signaling and Β‐adrenergic Signaling in Myocardial Infarction